We are live on
!
Find out more
CCM
Cullen Capital Management Portfolio holdings
AUM
$9.75B
1-Year Est. Return
21.81%
This Fund
S&P 500
This Quarter
Est. Return
+1.5%
1 Year Est. Return
+21.81%
3 Year Est. Return
+48.84%
5 Year Est. Return
+62.4%
10 Year Est. Return
+166.06%
AUM
$11.2B
AUM Growth
+$273M
(+2.5%)
Cap. Flow
+$141M
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
24.72%
Holding
306
New
31
Increased
125
Reduced
109
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$51.7M |
| 2 |
General Dynamics
GD
|
+$35M |
| 3 |
Coca-Cola Europacific Partners
CCEP
|
+$34.5M |
| 4 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$26M |
| 5 |
VE
VEOLIA ENVIRONNEMENT
VE
|
+$22.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$66.4M |
| 2 |
Intel
INTC
|
+$41.6M |
| 3 |
Broadcom
AVGO
|
+$37.9M |
| 4 |
Kontoor Brands
KTB
|
+$33.2M |
| 5 |
Vale
VALE
|
+$31.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Financials | 12.46% |
| 3 | Consumer Staples | 11.21% |
| 4 | Industrials | 11.01% |
| 5 | Technology | 7.92% |
Similar funds
FCM
URS
MPI
HL
DCP
CIM
MF
HI
Cullen Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Cullen Capital Management held 306 positions worth $11.2B, up 2.5% from $10.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Cullen Capital Management's Q2 2023 filing shows 31 new, 125 increased, 109 reduced and 12 closed positions. Its largest new stake was Baxter International: 1,188,029 shares worth $54.1M. The largest sale was Novartis, an estimated $66.4M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Financials and Consumer Staples.
- Cullen Capital Management's largest Q2 2023 buy was Baxter International: 1,188,029 shares worth $54.1M.
- Cullen Capital Management added most to General Dynamics in Q2 2023, an estimated $35M increase.
- Cullen Capital Management's biggest Q2 2023 reduction was Novartis, cutting an estimated $66.4M.
- Cullen Capital Management fully exited UBS Group in Q2 2023, selling an estimated $1.38M.
- Cullen Capital Management's ten largest holdings make up 25% of its $11.2B portfolio in Q2 2023.
- Cullen Capital Management opened 31 new positions and closed 12 in Q2 2023.
- Cullen Capital Management's portfolio value rose 2.5% quarter-over-quarter to $11.2B.
Based on Cullen Capital Management's 13F filing for Q2 2023, filed 15 Aug 2023.